{"symbol": "BPTH", "companyName": "Bio-Path Holdings Inc.", "exchange": "NASDAQ Capital Market", "industry": "Drug Manufacturers", "website": "http://www.biopathholdings.com", "description": "Bio-Path Holdings Inc is a clinical and preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.", "CEO": "Peter H. Nielsen", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Drug Manufacturers - Specialty & Generic", "Drug Manufacturers"]}